Microglia are crucial for the pathogenesis of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Here we show that the E3 ubiquitin ligase Peli1 is abundantly expressed in microglia and promotes microglial activation during the course of EAE induction. Peli1 mediates the induction of chemokines and proinflammatory cytokines in microglia and thereby promotes recruitment of T cells into the central nervous system. The severity of EAE is reduced in Peli1-deficient mice despite their competent induction of inflammatory T cells in the peripheral lymphoid organs. Notably, Peli1 regulates Toll-like receptor (TLR) pathway signaling by promoting degradation of TNF receptor-associated factor 3 (Traf3), a potent inhibitor of mitogen-activated protein kinase (MAPK) activation and gene induction. Ablation of Traf3 restores microglial activation and CNS inflammation after the induction of EAE in Peli1-deficient mice. These findings establish Peli1 as a microglia-specific mediator of autoimmune neuroinflammation and suggest a previously unknown signaling mechanism of Peli1 function. npg
Multiple sclerosis is an inflammatory disorder of the central nervous system (CNS) characterized by demyelination and axonal damage 1 . EAE is a widely used animal model for multiple sclerosis 2 . Initiation of EAE involves peripheral priming of myelin-specific autoimmune T helper type 1 (T H 1) and T H 17 cells and their subsequent migration into the CNS, where they become reactivated by antigen-presenting cells (APCs) presenting myelin-derived peptides. These pathological events culminate in disseminated CNS inflammation, leading to the destruction of oligodendrocytes and neurons, and the development of disease symptoms characterized by progressive paralysis 3 . The pathogenesis of EAE and multiple sclerosis also involve microglia [4] [5] [6] , which are innate immune cells that seed the CNS early during embryonic development and differ in ontogeny from bone marrow-derived monocytes and macrophages 7, 8 . Microglia sense microbial invasion and tissue damage and secrete chemokines and proinflammatory cytokines after activation, thereby promoting leukocyte recruitment into the CNS and the induction of inflammation 9, 10 . Activated microglia also function as APCs in the reactivation of T cells within the CNS 9, 11 .
Microbial infections are an environmental trigger for the onset and persistence of multiple sclerosis 1, 12 , as well as the induction of EAE [13] [14] [15] . Consistently, receptors that detect pathogen-associated molecular patterns, such as TLRs, have an important role in the regulation of multiple sclerosis and EAE 16 . In particular, the TLRs expressed on microglia are thought to mediate microglial activation and CNS inflammation [16] [17] [18] [19] . TLRs respond to both microbial components and endogenous damage-associated molecular patterns released from apoptotic cells or wounded tissues during the course of autoimmune inflammation. As a result of stimulation by their ligands, TLRs elicit cascades of signaling events that lead to activation of IκB kinase (IKK) and MAPKs, as well as their downstream transcription factors, nuclear factor κB (NF-κB), activator protein 1 (AP-1) and related DNA-binding proteins 20 . These transcription factors act cooperatively to induce the expression of a plethora of genes involved in leukocyte migration and inflammation 20 .
The TLR pathway that is dependent on the myeloid differentiation response factor MyD88 is particularly important for the pathogenesis of EAE 16, 17 . An E3 ubiquitin ligase, c-IAP, is required for the activation of MAPKs, although not of IKK, by the MyD88-dependent TLRs 21 . After activation by the TLR signals, c-IAP mediates Lys48 ubiquitination and degradation of Traf3, which is required for MAPK activation 21, 22 . However, the mechanism underlying this link between c-IAP and Traf3 in TLR signaling remains unclear. The Peli (also called Pellino) family of proteins has been implicated in the regulation of TLR and interkeukin-1 receptor (IL-1R) signaling in innate immune cells [23] [24] [25] . Mammalian cells express three highly homologous Peli members, which complicates the study of their in vivo functions because of potential functional redundancies. Our recent study suggests that in innate immune cells (macrophages and dendritic cells) and mouse embryonic fibroblasts (MEFs), Peli1 is dispensable for signal transduction by IL-1R and MyD88-dependent TLRs, although Peli1 has a nonredundant role in mediating NF-κB activation by the TRIF-dependent TLR pathway 26 . Whether Peli1 is required for MyD88-dependent TLR signaling in other cell types and how Peli1 regulates TLR signaling in vivo in pathological processes remain elusive. In the present study we discovered a crucial role for Peli1 in regulating microglial activation and EAE pathogenesis. We provide molecular and genetic evidence that Peli1 controls TLR-stimulated Traf3 degradation and MAPK activation.
RESULTS

Peli1-deficient mice are refractory to EAE induction
To study the role of Peli1 in CNS inflammation, we induced EAE in wild-type (WT) and Peli1 knockout mice using a myelin npg oligodendrocyte glycoprotein (MOG) peptide (MOG ). The WT mice developed severe clinical symptoms that were characterized by a gradual increase in the severity of paralysis ( Fig. 1a) , inflammatorycell infiltration into the CNS and demyelination ( Fig. 1b) . Despite the competent responses of T cells in the Peli1 knockout mice to antigen stimulation ( Supplementary Fig. 1 ), these mutant mice had decreased incidence of EAE, and if EAE developed, it was milder and characterized by lower clinical scores ( Fig. 1a,b ). This phenotype of the Peli1 knockout mice was associated with reduced frequencies and numbers of CNS-infiltrating T cells (CD4 + and CD8 + ), myeloid cells and activated resident microglial cells (CD11b + CD45 hi ) and total lymphocytes (CD11b − CD45 hi ), with a concomitant increase in the frequency and number of resting microglial cells (CD11b + CD45 lo ) ( Fig. 1c,d) .
After the induction of EAE, the CNS of Peli1 knockout mice also had greatly reduced numbers of T H 1 and T H 17 cells and accumulation of these cells in the draining lymph nodes as compared to WT immunized mice ( Fig. 1e) . Notably, the CNS of EAE-induced Peli1 knockout mice had reduced expression of various chemokines and inflammatory cytokines that are known to mediate immune-cell recruitment and inflammation as compared to WT immunized mice ( Fig. 1f) . These results suggest that recruitment of T cells into the CNS may be impaired in Peli1 knockout mice.
Peli1 in radioresistant cells regulates induction of EAE
To examine the cellular mechanism by which Peli1 regulates EAE pathogenesis, we passively induced EAE by adoptive transfer of npg activated MOG-specific T cells into sublethally irradiated WT and Peli1 knockout recipient mice. Transfer of WT T cells to WT recipient mice, but not to Peli1 knockout recipient mice, led to severe EAE disease, suggesting a role for Peli1 in radioresistant cells in mediating EAE pathogenesis ( Supplementary Fig. 2a ). Conversely, Peli1 was dispensable for the induction of EAE by T cells, as MOG-specific Peli1 knockout T cells were fully competent in inducing EAE in WT recipients ( Supplementary Fig. 2b ). We next generated radiation bone marrow chimeric (termed here GFP-chimeric) mice by reconstituting lethally irradiated WT or Peli1 knockout mice with WT bone marrow cells isolated from GFP-transgenic mice 27 . The WT GFP-chimeric mice were highly susceptible to EAE induction, whereas the Peli1 knockout GFPchimeric mice were refractory ( Fig. 2a) . A reverse bone marrow transfer experiment revealed that Peli1 was dispensable in bone marrow cells for EAE pathogenesis (Supplementary Fig. 3 ). These data further support a function for Peli1 in radioresistant cells in mediating EAE pathogenesis.
Using the GFP-chimeric mice described above, we determined whether Peli1 functions in CNS-resident cells to mediate the recruitment of immune cells into the CNS during the induction of EAE. On day 5 after EAE induction, the CNS of both the WT and Peli1 knockout chimeras had a low frequency of immune (GFP + ) cells (Fig. 2b,c) . Over time, the frequency of the CNS-infiltrating immune cells was substantially increased in the WT but not the Peli1 knockout chimeras (Fig. 2b,c) . Similarly, recruitment of CD4 + T cells into the CNS of Peli1 knockout chimeras was impaired ( Fig. 2d,e ). This was not caused by a defect in donor T cell activation, as the spleens of these mutant chimeras contained a higher number of donor CD4 + T cells compared to the spleens of WT chimeras (Fig. 2f) . The CNS of Peli1 knockout GFP-chimeric mice had considerably reduced expression of proinflammatory cytokine and chemokine genes (Fig. 2g) . Thus, Peli1 may function within CNS-resident cells to mediate the induction of genes involved in immune-cell recruitment and inflammation.
Peli1 has a microglia-specific role in EAE regulation The brain and spinal cord were among the tissues with the highest Peli1 expression in WT mice (Supplementary Fig. 4a ). In particular, Peli1 was the predominant Peli family member expressed in microglia, whereas at least two of the three Peli family members were comparably expressed in astrocytes, oligodendrocyte precursor cells (OPCs) and neurons ( Fig. 3a and Supplementary Fig. 4b ) or innate immune cells 28 . Furthermore, Peli1, but not the other Peli family members, was induced in microglia by in vitro stimulation with lipopolysaccharide (LPS) ( Fig. 3b and Supplementary Fig. 4c,d) . Expression of Peli1 was also increased in microglia after the induction of EAE in vivo (Fig. 3c) , albeit transiently (Supplementary Fig. 4e) .
To examine whether Peli1 is required for microglial activation during EAE, we used the GFP-chimeric mice to distinguish between infiltrating macrophages (CD11b + GFP + ) and CNS-resident microglia (CD11b + GFP − ). We detected microglial activation on the basis of their well-defined induction of CD45 and MHC class II (MHC II) 5 . After EAE induction, WT chimeras had a substantially increased frequency of activated microglia (CD45 hi MHC II + GFP − ) and a decreased frequency of resting microglia (CD45 lo MHC II − GFP − ), whereas the Peli1 knockout chimeras contained predominantly resting microglia ( Fig. 3d,e) . In vitro LPS-stimulated MHC II expression was also npg impaired in purified Peli1-deficient microglia (Fig. 3f) . The Peli1deficient microglia, isolated from EAE-induced Peli1 knockout and WT chimera mice, also had impaired expression of proinflammatory cytokine and chemokine genes (Fig. 3g) . These results suggest the requirement of Peli1 for EAE-associated microglial activation. As a more direct approach to examine the microglia-specific function of Peli1 in mediating EAE pathogenesis, we stereotaxically injected purified microglia (Supplementary Fig. 4f ) into the cerebrospinal fluid of Peli1 knockout mice. Injection of WT microglia, but not Peli1 knockout microglia, rendered the Peli1 knockout mice highly sensitive to EAE induction (Fig. 3h) . These data further emphasize a microglia-specific role for Peli1 in mediating CNS inflammation and EAE induction.
Peli1 mediates TLR-stimulated gene expression in microglia
Although microglia did not appreciably respond to the TLR3 ligand, poly(I:C), they responded to several ligands of MyD88-dependent TLRs, including LPS (TLR4), CpG (TLR9), R837 (TLR7) and Pam 3 CSK 4 (TLR1 and TLR2), leading to the induction of several proinflammatory cytokine and chemokine genes (Fig. 4a,b) . The Peli1 deficiency severely attenuated gene induction by these MyD88-dependent TLR ligands (Fig. 4a,b and Supplementary Fig. 5 ).
EAE pathogenesis also involves CNS-resident astrocytes, which respond to proinflammatory cytokines such as IL-17, interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). However, Peli1 deficiency did not appreciably affect inflammatory responses in astrocytes (Supplementary Fig. 6 ). This result suggests a dispensable role for Peli1 in IL-17R signaling or a functional redundancy of Peli1 with other Peli family members that are also expressed in astrocytes (Fig. 3a) .
Peli1 mediates TLR-stimulated MAPK activation in microglia
We have previously shown that Peli1 mediates NF-κB activation by the TRIF-dependent TLR pathway but is dispensable for the MyD88-dependent TLR pathway in MEFs 26 . Similarly, we found that loss of Peli1 in microglia impaired poly(I:C)-mediated activation of NF-κB through TLR3 ( Supplementary  Fig. 7a) . In contrast, Peli1 was dispensable for NF-κB activation by the MyD88-dependent TLR ligand Pam 3 CSK 4 ( Supplementary  Fig. 7c ). LPS-induced NF-κB activation in Peli1-deficient microglia was partially defective ( Supplementary Fig. 7b) , reflecting the fact that LPS stimulates both TRIF-and MyD88-dependent pathways 20 . These results further emphasize that Peli1 regulates NF-κB activation specifically in the TRIF-dependent TLR pathway. The requirement of Peli1 in gene induction by MyD88-dependent TLRs in microglia (Fig. 4a,b) suggested a previously unknown signaling function of Peli1. Indeed, Peli1 deficiency severely attenuated the LPS-stimulated activation of three major families of MAPKs: ERK, JNK and p38 (Fig. 4c) . This function of Peli1 seemed to involve the MyD88-dependent pathway, as Peli1 was also required for MAPK activation by Pam 3 CSK 4 (Fig. 4d) .
Peli1 mediates c-IAP ubiquitination and TRAF3 degradation
After stimulation by LPS, activated Traf6 undergoes autoubiquitination 23, 24 and mediates MAPK activation by inducing Lys63 ubiquitination of c-IAP, a modification that triggers the ubiquitin ligase activity of c-IAP 21, 22 . We found that the Peli1 deficiency did not inhibit Traf6 ubiquitination but severely attenuated c-IAP2 ubiquitination in LPS-stimulated microglia (Fig. 5a) . As Traf6 is required for Peli1 activation 29 , we surmised that Peli1 might mediate Traf6induced c-IAP2 ubiquitination. We found that although both Traf6 and Peli1 induced Lys63 ubiquitination of c-IAP2, WT Peli1 substantially promoted Traf6-mediated c-IAP2 ubiquitination ( Fig. 5b and  Supplementary Fig. 8a) . Conversely, Traf6-induced c-IAP2 ubiquitination was blocked by expression of the Peli1 RING-deletion mutant (Peli1∆C) (Fig. 5b) or by knocking down endogenous Peli1 using shRNA (Fig. 5c) . Moreover, LPS-stimulated Lys63 ubiquitination of c-IAP2 was attenuated in Peli1-deficient microglia ( Supplementary  Fig. 8b) . These results suggest that Peli1 is essential for the induction of c-IAP ubiquitination by LPS and Traf6.
An important function of c-IAP in the TLR pathway is to mediate Lys48 ubiquitination and degradation of Traf3, thereby triggering MAPK activation 21, 22 . We found that LPS stimulated rapid degradation of Traf3 in WT microglia (Fig. 5d) , although such a signaling event was much less pronounced in bone marrow-derived macrophages (data not shown). LPS-stimulated Traf3 degradation was blocked in Peli1-deficient microglia (Fig. 5d) , which could be rescued by reconstitution with exogenous Peli1 (Supplementary  Fig. 9a) . Consistently, LPS stimulated Traf3 Lys48 ubiquitination in WT microglia, which was diminished in Peli1-deficient microglia ( Fig. 5e) . A parallel experiment revealed that the TLR2 ligand Pam 3 CSK 4 also induced Traf3 degradation in WT, but not Peli1deficient, microglia (Supplementary Fig. 9b ). Of note, after the induction of EAE, Traf3 expression was gradually depleted in the microglia of WT mice but accumulated in the microglia of Peli1 knockout mice (Fig. 5f) . Thus, Peli1 mediates ubiquitin-dependent Traf3 degradation both in vitro after TLR stimulation and in vivo along with EAE induction.
Consistent with a recent report that IKKi (also known as IKKε) activates Peli1 (ref. 30) , we found that overexpressed Peli1 induced Traf3 ubiquitination, which was promoted by IKKi ( Fig. 5g) . Because c-IAP is known as an E3 of Traf3 (ref. 21) , we asked whether Peli1induced Traf3 ubiquitination required c-IAP. We found that Peli1induced Traf3 ubiquitination was blocked in cells treated with the c-IAP inhibitor Smac mimetic [31] [32] [33] (Fig. 5h) or transfected with the c-IAP1 and c-IAP2 shRNAs (Supplementary Fig. 10 ). Collectively, these results suggest that Peli1 activates c-IAP and participates in c-IAP-mediated Traf3 ubiquitination and degradation.
Traf3 ablation restores EAE in Peli1 knockout mice
To assess the functional importance of Traf3 degradation in mediating microglial activation, we knocked down Traf3 in Peli1-deficient microglia. Infection of the Peli1 knockout microglia with a Traf3specific shRNA, but not a control shRNA vector, largely rescued their defect in LPS-stimulated gene induction (Fig. 6a) . Consistent with this in vitro finding, Traf3 flox/flox LysM-Cre mice, which had specific Traf3 ablation in microglia and other myeloid-lineage cells, npg developed more severe EAE than control Traf3 +/+ LysM-Cre mice (Supplementary Fig. 11a ). This phenotype was not caused by an increase in the number of IFN-γ + or IL-17 + CD4 + T cells in draining lymph nodes (Supplementary Fig. 11b ) or in the recall responses of MOG-specific T cells (Supplementary Fig. 11c) . Conversely, microglia derived from Traf3 flox/flox LysM-Cre mice were hyper-responsive to LPS-stimulated expression of proinflammatory cytokine and chemokine genes (Supplementary Fig. 11d) .
The ablation of Traf3 in myeloid cells also rescued the defects of Peli1 knockout mice in EAE induction ( Fig. 6b) and in the infiltration of T cells and CD45 + CD11b + myeloid cells into the CNS (Fig. 6c,d) . Moreover, Traf3 ablation rescued the microglial activation defect of Peli1 knockout mice, as evidenced by the lack of accumulation of a resting microglial population (CD45 lo CD11b + ) (Fig. 6c) . Taken together, these in vitro and in vivo studies highlight the functional importance of Peli1-mediated Traf3 degradation in mediating microglial activation and CNS inflammation.
DISCUSSION
Microglial activation is an early event in the development of CNS inflammatory disorders, and ablation or functional inhibition of microglia reduces clinical scores after the induction of EAE without affecting peripheral T cell activation, emphasizing the promise of targeting microglial activation in the treatment of multiple sclerosis 4, 34 . In the present study we identified the E3 ubiquitin ligase Peli1 as a pivotal mediator of microglial activation and EAE pathogenesis. We have previously shown that peripheral innate immune cells and MEFs express different Peli family members at comparable levels 28 , which suggests functional redundancies in some of their functions and explains why loss of Peli1 in peripheral innate immune cells selectively affects TRIF-dependent TLR signaling in the NF-κB pathway 26 . Here we found that microglia predominantly expressed Peli1 and required Peli1 for their activation during the course of EAE induction and TLR stimulation. In addition to attenuated TRIF-dependent NF-κB activation, Peli1-deficient microglia had impaired activation of MAPKs stimulated by MyD88-dependent TLRs. Similarly to microglia, T cells predominantly express Peli1; however, Peli1 is a negative regulator of T cell activation 28 . In contrast to microglia, several other CNS cell types, including astrocytes, OPCs and neurons, express different Peli family members at comparable levels. Although the role of Peli1 in mediating TLR signaling in these cell types needs to be studied further, the pattern of Peli expression predicts functional redundancy.
Microglia form a major population of CNS APCs that become activated after the induction of EAE 10 . We found that Peli1 is crucial for mediating microglial activation both in vivo after EAE induction and after LPS stimulation. These findings suggest the requirement of Peli1 in T cell activation within the CNS. Peli1 is also required for the induction of proinflammatory cytokines and chemokines in microglia, which explains why Peli1 deficiency impairs immune-cell infiltration into the CNS and reduces the severity of EAE.
A major signaling function of Peli1 in microglia is to mediate the activation of MAPKs by MyD88-dependent TLRs. Peli1 deficiency did not interfere with the TLR-mediated activation of Traf6 but rather seemed to prevent Traf6 from mediating the Lys63 ubiquitination of c-IAP. Our data are in line with the recent report that Peli1 is a downstream target of Traf6 in the MyD88-dependent TLR pathway 29 . The Lys63 ubiquitination of c-IAP is known to trigger its Lys48 ubiquitin ligase activity, allowing c-IAP to engage ubiquitin-dependent degradation of Traf3 (refs. 21, 22) . Consistently, Peli1 was required for Traf3 degradation in microglia both in vitro after TLR stimulation and in vivo after the induction of EAE. By different approaches, we demonstrated that Traf3 accumulation in Peli1-deficient microglia contributes to the impaired inflammatory responses in Peli1 knockout mice. Our data are in agreement with a previous report that Traf3 suppresses IL-17-stimulated signaling and EAE pathogenesis in radioresistant cells, which may include CNS cells 35 . As IL-17 does not induce Traf3 degradation 35 , it is probable that Peli1 is not involved directly in IL-17R signaling, and that Peli1-mediated Traf3 degradation in the TLR pathway may indirectly promote IL-17R signaling.
It is currently unclear whether Peli1 is involved in the pathogenesis of human multiple sclerosis. Nevertheless, a recently published microarray data set suggests elevated PELI1 expression in the initial white matter lesion areas of multiple sclerosis brains 36 (GSE32915). We also performed microarray studies to analyze gene expression in the gray matters of several multiple sclerosis and non-multiple sclerosis brains. Although PELI1 expression was largely comparable between the multiple sclerosis and non-multiple sclerosis samples, one multiple sclerosis sample showed a markedly higher level of PELI1 expression ( Supplementary Fig. 12 and Supplementary Table 1 ). One technical issue was that the brain tissues contained only a small percentage of microglial cells. Nevertheless, these human study data generally suggest that the expression of PELI1 is altered in multiple sclerosis.
In summary, our work establishes Peli1 as a mediator of microglial activation and EAE pathogenesis. On the basis of our data, we propose a model in which Peli1 functions downstream of Traf6 in the MyD88-dependent TLR pathway to mediate the activation of c-IAP and the induction of ubiquitin-dependent degradation of Traf3, thereby contributing to the activation of MAPKs and the induction of genes involved in microglial activation and CNS inflammation.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
